What is Beam Therapeutics's other long-term liabilities?

Beam Therapeutics (BEAM) reported other long-term liabilities of $134K in Q1 2026.

How has Beam Therapeutics's other long-term liabilities changed year-over-year?

Beam Therapeutics's other long-term liabilities increased by 250.6% year-over-year, from -$89K to $134K.

What is the long-term trend for Beam Therapeutics's other long-term liabilities?

Over 3 years (2021 to 2025), Beam Therapeutics's other long-term liabilities has grown at a -43.1% compound annual growth rate (CAGR), from $1.79M to -$330K.

Beam Therapeutics BEAM Other long-term liabilities

Other long-term liabilities at other companies

Hilton WorldwideHLT

-$14M+3.4%

MSCIMSCI

$4.9M+644%

American TowerAMT

$12.55M+129%

Bloom EnergyBE

-$86K-126%

Meta Platforms, Inc.META

-$5.17B-827%

Rocket Lab USA, Inc.RKLB

$71K-71.0%

Other financials

Income statement

See full

Revenue$31.7M+325%

Operating income-$107.2M+10.1%

Net income-$94.3M+12.9%

EPS (diluted)-$0.91+26.0%

Balance sheet

See full

Cash & equivalents$288.3M-45.4%

Total debt$250.8M+58.6%

Total equity$1.2B+3.1%

Total assets$1.5B+0.9%

Cash flow

See full

Operating cash flow-$128.5M-23.7%

CapEx$2.2M-27.2%

Free cash flow-$130.7M-22.2%

Valuation

See full

Market cap$3.42B+24.5%

Profitability

See full

Operating margin-226.6%-90.5pp

Net margin-742.7%—

FCF margin-234%-86.6pp

Returns & leverage

See full

Return on equity-47.1%—

Debt / equity0.2×+0.1×

Current ratio17×+8.2×

Where this comes from

Reported directly by Beam Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.

The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's other long-term liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beam Therapeutics's other long-term liabilities?: Beam Therapeutics (BEAM) reported other long-term liabilities of $134K in Q1 2026.
How has Beam Therapeutics's other long-term liabilities changed year-over-year?: Beam Therapeutics's other long-term liabilities increased by 250.6% year-over-year, from -$89K to $134K.
What is the long-term trend for Beam Therapeutics's other long-term liabilities?: Over 3 years (2021 to 2025), Beam Therapeutics's other long-term liabilities has grown at a -43.1% compound annual growth rate (CAGR), from $1.79M to -$330K.